SAGE Therapeutics (SAGE) Tops Q4 EPS by 24c

SAGE Therapeutics (NASDAQ: SAGE) reported Q4 EPS of ($1.75), $0.24 better than the analyst estimate of ($1.99).

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy